Innate immunity, coagulation and placenta-related adverse pregnancy outcomes.
about
Innate immunity, decidual cells, and preeclampsiaPregnancy-specific glycoproteins bind integrin αIIbβ3 and inhibit the platelet-fibrinogen interactionEnvironmental impact on vascular development predicted by high-throughput screening.Lipidomic assessment of plasma and placenta of women with early-onset preeclampsia.Recurrent miscarriage: causes, evaluation and management.Genetic, biochemical, and environmental factors associated with pregnancy outcomes in newborns from the Czech RepublicStructural genomic variation as risk factor for idiopathic recurrent miscarriage.The physiologic and therapeutic role of heparin in implantation and placentation.Single administration of ultra-low-dose lipopolysaccharide in rat early pregnancy induces TLR4 activation in the placenta contributing to preeclampsia.Chinese herbal medicine for miscarriage affects decidual micro-environment and fetal growth.Intrauterine growth restriction: cytokine profiles of trophoblast antigen-stimulated maternal lymphocytes.Prevention of Defective Placentation and Pregnancy Loss by Blocking Innate Immune Pathways in a Syngeneic Model of Placental Insufficiency.Perinatal Arterial Ischemic Stroke Is Associated to Materno-Fetal Immune Activation and Intracranial Arteritis.Multiple pregnancy failures: an immunological paradigm.Impact of Maternal Serotonin Transporter Genotype on Placental Serotonin, Fetal Forebrain Serotonin, and Neurodevelopment.Formyl peptide receptor-2 is decreased in fetal growth restriction and contributes to placental dysfunction.
P2860
Q27014127-0238CA82-ACCD-41B5-90F3-76CE6B43A160Q28595015-0808EEE4-7EAA-4A2B-86EB-F6206600E585Q33970802-F93CD9FB-DE8A-43CA-937D-EDB2C54F20D9Q34362275-718829A7-8885-456C-A5F6-DEDC1CF5ECADQ34462726-EB1C5E60-688B-49A0-935F-E97F3F40624CQ34580944-6222AC63-7DAA-4343-9028-52A4F94E6EEAQ34842111-DFBB6D9D-CD24-4262-966A-C0EC6D79215AQ35007371-BF0132D9-80B2-42A7-A64C-B39A8C812B4AQ35324147-39BD296C-ED99-4AA3-8B19-8371F30290B9Q35395913-2CF7717F-904C-423D-B322-B7CEE1E82F8FQ35495522-165BD89C-9370-493C-986B-180A63E4E01DQ35864583-849F2C6B-AE20-4E0B-ABF3-8F687738B7BFQ37534530-2A0F2DF5-F27F-4310-A5ED-ED66D229ABB8Q37989553-4168C03C-75CC-4FB2-ADF4-BDD973F2F70AQ39464602-683D413F-2EA4-48D0-9A47-5CE6D3CC0EB1Q47186466-013A4213-9C1A-491F-84DD-C53F27224621
P2860
Innate immunity, coagulation and placenta-related adverse pregnancy outcomes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Innate immunity, coagulation and placenta-related adverse pregnancy outcomes.
@en
Innate immunity, coagulation and placenta-related adverse pregnancy outcomes.
@nl
type
label
Innate immunity, coagulation and placenta-related adverse pregnancy outcomes.
@en
Innate immunity, coagulation and placenta-related adverse pregnancy outcomes.
@nl
prefLabel
Innate immunity, coagulation and placenta-related adverse pregnancy outcomes.
@en
Innate immunity, coagulation and placenta-related adverse pregnancy outcomes.
@nl
P2860
P1433
P1476
Innate immunity, coagulation and placenta-related adverse pregnancy outcomes.
@en
P2093
S Joseph Huang
P2860
P304
P356
10.1016/J.THROMRES.2009.07.012
P577
2009-08-14T00:00:00Z